108 related articles for article (PubMed ID: 23313295)
1. Gene expression profile of aquaporin 1 and associated interactors in malignant pleural mesothelioma.
Jagirdar R; Solenov EI; Hatzoglou C; Molyvdas PA; Gourgoulianis KI; Zarogiannis SG
Gene; 2013 Mar; 517(1):99-105. PubMed ID: 23313295
[TBL] [Abstract][Full Text] [Related]
2. Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction.
López-Ríos F; Chuai S; Flores R; Shimizu S; Ohno T; Wakahara K; Illei PB; Hussain S; Krug L; Zakowski MF; Rusch V; Olshen AB; Ladanyi M
Cancer Res; 2006 Mar; 66(6):2970-9. PubMed ID: 16540645
[TBL] [Abstract][Full Text] [Related]
3. Aquaporin 1 is an independent prognostic factor in pleural malignant mesothelioma.
Kao SC; Armstrong N; Condon B; Griggs K; McCaughan B; Maltby S; Wilson A; Henderson DW; Klebe S
Cancer; 2012 Jun; 118(11):2952-61. PubMed ID: 22020536
[TBL] [Abstract][Full Text] [Related]
4. Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA.
Henderson DW; Reid G; Kao SC; van Zandwijk N; Klebe S
J Clin Pathol; 2013 Oct; 66(10):854-61. PubMed ID: 23833051
[TBL] [Abstract][Full Text] [Related]
5. Microdissection, mRNA amplification and microarray: a study of pleural mesothelial and malignant mesothelioma cells.
Mohr S; Bottin MC; Lannes B; Neuville A; Bellocq JP; Keith G; Rihn BH
Biochimie; 2004 Jan; 86(1):13-9. PubMed ID: 14987796
[TBL] [Abstract][Full Text] [Related]
6. Gene copy number analysis in malignant pleural mesothelioma using oligonucleotide array CGH.
Lindholm PM; Salmenkivi K; Vauhkonen H; Nicholson AG; Anttila S; Kinnula VL; Knuutila S
Cytogenet Genome Res; 2007; 119(1-2):46-52. PubMed ID: 18160781
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional profiling of mesothelioma using microarrays.
Gordon GJ
Lung Cancer; 2005 Jul; 49 Suppl 1():S99-S103. PubMed ID: 15950812
[TBL] [Abstract][Full Text] [Related]
8. Advances in the systemic therapy of malignant pleural mesothelioma.
Fennell DA; Gaudino G; O'Byrne KJ; Mutti L; van Meerbeeck J
Nat Clin Pract Oncol; 2008 Mar; 5(3):136-47. PubMed ID: 18227828
[TBL] [Abstract][Full Text] [Related]
9. [Asbestos and malignant pleural mesothelioma: molecular, cellular and physiopathological aspects].
Mohr S; Keith G; Rihn B
Bull Cancer; 2005 Nov; 92(11):959-76. PubMed ID: 16316830
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Expression of Aquaporin-1 in Fluoro-Edenite-Induced Malignant Mesothelioma: A Preliminary Report.
Angelico G; Caltabiano R; Loreto C; Ieni A; Tuccari G; Ledda C; Rapisarda V
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495596
[TBL] [Abstract][Full Text] [Related]
11. Genetics of malignant pleural mesothelioma: molecular markers and biologic targets.
Bueno R; Gordon GJ
Thorac Surg Clin; 2004 Nov; 14(4):461-8. PubMed ID: 15559052
[TBL] [Abstract][Full Text] [Related]
12. Implications of P16/CDKN2A deletion in pleural mesotheliomas.
Ladanyi M
Lung Cancer; 2005 Jul; 49 Suppl 1():S95-8. PubMed ID: 15950811
[TBL] [Abstract][Full Text] [Related]
13. Computational genomic analysis of PARK7 interactome reveals high BBS1 gene expression as a prognostic factor favoring survival in malignant pleural mesothelioma.
Vavougios GD; Solenov EI; Hatzoglou C; Baturina GS; Katkova LE; Molyvdas PA; Gourgoulianis KI; Zarogiannis SG
Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(7):L677-86. PubMed ID: 26254420
[TBL] [Abstract][Full Text] [Related]
14. CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesothelioma.
Aoe K; Amatya VJ; Fujimoto N; Ohnuma K; Hosono O; Hiraki A; Fujii M; Yamada T; Dang NH; Takeshima Y; Inai K; Kishimoto T; Morimoto C
Clin Cancer Res; 2012 Mar; 18(5):1447-56. PubMed ID: 22261805
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling.
Gordon GJ; Rockwell GN; Jensen RV; Rheinwald JG; Glickman JN; Aronson JP; Pottorf BJ; Nitz MD; Richards WG; Sugarbaker DJ; Bueno R
Am J Pathol; 2005 Jun; 166(6):1827-40. PubMed ID: 15920167
[TBL] [Abstract][Full Text] [Related]
16. [Molecular heterogeneity of malignant pleural mesotheliomas].
Tranchant R; Montagne F; Jaurand MC; Jean D
Bull Cancer; 2018 Jan; 105(1):35-45. PubMed ID: 29277245
[TBL] [Abstract][Full Text] [Related]
17. Influence of AQP1 on cell adhesion, migration, and tumor sphere formation in malignant pleural mesothelioma is substratum- and histological-type dependent.
Jagirdar RM; Apostolidou E; Molyvdas PA; Gourgoulianis KI; Hatzoglou C; Zarogiannis SG
Am J Physiol Lung Cell Mol Physiol; 2016 Mar; 310(6):L489-95. PubMed ID: 26773069
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications.
Busacca S; Germano S; De Cecco L; Rinaldi M; Comoglio F; Favero F; Murer B; Mutti L; Pierotti M; Gaudino G
Am J Respir Cell Mol Biol; 2010 Mar; 42(3):312-9. PubMed ID: 19502386
[TBL] [Abstract][Full Text] [Related]
19. A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma.
Enomoto Y; Kasai T; Takeda M; Takano M; Morita K; Kadota E; Iizuka N; Maruyama H; Haratake J; Kojima Y; Ikeda N; Nonomura A
Pathol Int; 2012 Apr; 62(4):226-31. PubMed ID: 22449226
[TBL] [Abstract][Full Text] [Related]
20. Contemporary approaches in the investigation and treatment of malignant pleural mesothelioma.
Pass HI
Chest Surg Clin N Am; 1994 Aug; 4(3):497-515. PubMed ID: 7953481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
